nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—ovarian cancer	0.425	1	CbGaD
Reboxetine—ABCB1—Topotecan—ovarian cancer	0.0662	0.184	CbGbCtD
Reboxetine—ABCB1—Vinorelbine—ovarian cancer	0.0466	0.13	CbGbCtD
Reboxetine—CYP2D6—Vinorelbine—ovarian cancer	0.0439	0.122	CbGbCtD
Reboxetine—CYP3A4—Topotecan—ovarian cancer	0.0396	0.11	CbGbCtD
Reboxetine—ABCB1—Paclitaxel—ovarian cancer	0.0328	0.0911	CbGbCtD
Reboxetine—CYP3A4—Vinorelbine—ovarian cancer	0.0279	0.0777	CbGbCtD
Reboxetine—ABCB1—Docetaxel—ovarian cancer	0.0237	0.0659	CbGbCtD
Reboxetine—CYP3A4—Paclitaxel—ovarian cancer	0.0196	0.0546	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—ovarian cancer	0.0177	0.0491	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—ovarian cancer	0.0166	0.0463	CbGbCtD
Reboxetine—CYP3A4—Docetaxel—ovarian cancer	0.0142	0.0395	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—ovarian cancer	0.0106	0.0294	CbGbCtD
Reboxetine—Anxiety—Paclitaxel—ovarian cancer	0.00025	0.00116	CcSEcCtD
Reboxetine—Face oedema—Doxorubicin—ovarian cancer	0.00025	0.00116	CcSEcCtD
Reboxetine—Malnutrition—Docetaxel—ovarian cancer	0.00025	0.00116	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000249	0.00115	CcSEcCtD
Reboxetine—Nausea—Topotecan—ovarian cancer	0.000248	0.00115	CcSEcCtD
Reboxetine—Discomfort—Paclitaxel—ovarian cancer	0.000248	0.00115	CcSEcCtD
Reboxetine—Muscular weakness—Epirubicin—ovarian cancer	0.000247	0.00114	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000247	0.00114	CcSEcCtD
Reboxetine—Dry mouth—Paclitaxel—ovarian cancer	0.000245	0.00114	CcSEcCtD
Reboxetine—Diarrhoea—Vinorelbine—ovarian cancer	0.000244	0.00113	CcSEcCtD
Reboxetine—Dysgeusia—Docetaxel—ovarian cancer	0.000244	0.00113	CcSEcCtD
Reboxetine—Nausea—Melphalan—ovarian cancer	0.000243	0.00113	CcSEcCtD
Reboxetine—Confusional state—Paclitaxel—ovarian cancer	0.000242	0.00112	CcSEcCtD
Reboxetine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000242	0.00112	CcSEcCtD
Reboxetine—Influenza—Epirubicin—ovarian cancer	0.000242	0.00112	CcSEcCtD
Reboxetine—Dehydration—Doxorubicin—ovarian cancer	0.000241	0.00111	CcSEcCtD
Reboxetine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000239	0.00111	CcSEcCtD
Reboxetine—Infection—Paclitaxel—ovarian cancer	0.000239	0.00111	CcSEcCtD
Reboxetine—Shock—Paclitaxel—ovarian cancer	0.000236	0.0011	CcSEcCtD
Reboxetine—Dizziness—Vinorelbine—ovarian cancer	0.000236	0.00109	CcSEcCtD
Reboxetine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000236	0.00109	CcSEcCtD
Reboxetine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000236	0.00109	CcSEcCtD
Reboxetine—Tachycardia—Paclitaxel—ovarian cancer	0.000235	0.00109	CcSEcCtD
Reboxetine—Breast disorder—Doxorubicin—ovarian cancer	0.000234	0.00108	CcSEcCtD
Reboxetine—Skin disorder—Paclitaxel—ovarian cancer	0.000233	0.00108	CcSEcCtD
Reboxetine—Bronchitis—Epirubicin—ovarian cancer	0.000232	0.00108	CcSEcCtD
Reboxetine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000232	0.00108	CcSEcCtD
Reboxetine—Anaemia—Docetaxel—ovarian cancer	0.000231	0.00107	CcSEcCtD
Reboxetine—Anorexia—Paclitaxel—ovarian cancer	0.000229	0.00106	CcSEcCtD
Reboxetine—Muscular weakness—Doxorubicin—ovarian cancer	0.000228	0.00106	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000228	0.00106	CcSEcCtD
Reboxetine—Vomiting—Vinorelbine—ovarian cancer	0.000227	0.00105	CcSEcCtD
Reboxetine—Dysuria—Epirubicin—ovarian cancer	0.000226	0.00105	CcSEcCtD
Reboxetine—Rash—Vinorelbine—ovarian cancer	0.000225	0.00104	CcSEcCtD
Reboxetine—Dermatitis—Vinorelbine—ovarian cancer	0.000225	0.00104	CcSEcCtD
Reboxetine—Hypotension—Paclitaxel—ovarian cancer	0.000225	0.00104	CcSEcCtD
Reboxetine—Headache—Vinorelbine—ovarian cancer	0.000224	0.00104	CcSEcCtD
Reboxetine—Syncope—Docetaxel—ovarian cancer	0.000224	0.00104	CcSEcCtD
Reboxetine—Influenza—Doxorubicin—ovarian cancer	0.000224	0.00104	CcSEcCtD
Reboxetine—Leukopenia—Docetaxel—ovarian cancer	0.000223	0.00104	CcSEcCtD
Reboxetine—Pollakiuria—Epirubicin—ovarian cancer	0.000223	0.00103	CcSEcCtD
Reboxetine—Palpitations—Docetaxel—ovarian cancer	0.000221	0.00102	CcSEcCtD
Reboxetine—Loss of consciousness—Docetaxel—ovarian cancer	0.000219	0.00102	CcSEcCtD
Reboxetine—Weight decreased—Epirubicin—ovarian cancer	0.000219	0.00101	CcSEcCtD
Reboxetine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000218	0.00101	CcSEcCtD
Reboxetine—Insomnia—Paclitaxel—ovarian cancer	0.000217	0.00101	CcSEcCtD
Reboxetine—Paraesthesia—Paclitaxel—ovarian cancer	0.000216	0.001	CcSEcCtD
Reboxetine—Hypertension—Docetaxel—ovarian cancer	0.000216	0.000999	CcSEcCtD
Reboxetine—Infestation NOS—Epirubicin—ovarian cancer	0.000215	0.000998	CcSEcCtD
Reboxetine—Infestation—Epirubicin—ovarian cancer	0.000215	0.000998	CcSEcCtD
Reboxetine—Bronchitis—Doxorubicin—ovarian cancer	0.000215	0.000996	CcSEcCtD
Reboxetine—Dyspnoea—Paclitaxel—ovarian cancer	0.000214	0.000993	CcSEcCtD
Reboxetine—Somnolence—Paclitaxel—ovarian cancer	0.000214	0.00099	CcSEcCtD
Reboxetine—Chest pain—Docetaxel—ovarian cancer	0.000213	0.000985	CcSEcCtD
Reboxetine—Nausea—Vinorelbine—ovarian cancer	0.000212	0.000983	CcSEcCtD
Reboxetine—Dyspepsia—Paclitaxel—ovarian cancer	0.000212	0.00098	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000211	0.000978	CcSEcCtD
Reboxetine—Urinary tract infection—Epirubicin—ovarian cancer	0.000209	0.00097	CcSEcCtD
Reboxetine—Conjunctivitis—Epirubicin—ovarian cancer	0.000209	0.00097	CcSEcCtD
Reboxetine—Dysuria—Doxorubicin—ovarian cancer	0.000209	0.000969	CcSEcCtD
Reboxetine—Decreased appetite—Paclitaxel—ovarian cancer	0.000209	0.000968	CcSEcCtD
Reboxetine—Dry mouth—Docetaxel—ovarian cancer	0.000208	0.000963	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000208	0.000961	CcSEcCtD
Reboxetine—Sweating—Epirubicin—ovarian cancer	0.000207	0.000957	CcSEcCtD
Reboxetine—Pollakiuria—Doxorubicin—ovarian cancer	0.000207	0.000957	CcSEcCtD
Reboxetine—Constipation—Paclitaxel—ovarian cancer	0.000206	0.000952	CcSEcCtD
Reboxetine—Confusional state—Docetaxel—ovarian cancer	0.000205	0.000952	CcSEcCtD
Reboxetine—Epistaxis—Epirubicin—ovarian cancer	0.000203	0.000942	CcSEcCtD
Reboxetine—Infection—Docetaxel—ovarian cancer	0.000202	0.000938	CcSEcCtD
Reboxetine—Weight decreased—Doxorubicin—ovarian cancer	0.000202	0.000937	CcSEcCtD
Reboxetine—Sinusitis—Epirubicin—ovarian cancer	0.000202	0.000937	CcSEcCtD
Reboxetine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000202	0.000935	CcSEcCtD
Reboxetine—Shock—Docetaxel—ovarian cancer	0.0002	0.000929	CcSEcCtD
Reboxetine—Nervous system disorder—Docetaxel—ovarian cancer	0.0002	0.000926	CcSEcCtD
Reboxetine—Infestation NOS—Doxorubicin—ovarian cancer	0.000199	0.000924	CcSEcCtD
Reboxetine—Infestation—Doxorubicin—ovarian cancer	0.000199	0.000924	CcSEcCtD
Reboxetine—Tachycardia—Docetaxel—ovarian cancer	0.000199	0.000921	CcSEcCtD
Reboxetine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000198	0.000918	CcSEcCtD
Reboxetine—Skin disorder—Docetaxel—ovarian cancer	0.000198	0.000917	CcSEcCtD
Reboxetine—Bradycardia—Epirubicin—ovarian cancer	0.000197	0.000912	CcSEcCtD
Reboxetine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000197	0.000911	CcSEcCtD
Reboxetine—Anorexia—Docetaxel—ovarian cancer	0.000194	0.0009	CcSEcCtD
Reboxetine—Rhinitis—Epirubicin—ovarian cancer	0.000194	0.000898	CcSEcCtD
Reboxetine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000194	0.000898	CcSEcCtD
Reboxetine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000194	0.000898	CcSEcCtD
Reboxetine—Pharyngitis—Epirubicin—ovarian cancer	0.000192	0.000889	CcSEcCtD
Reboxetine—Sweating—Doxorubicin—ovarian cancer	0.000191	0.000886	CcSEcCtD
Reboxetine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000191	0.000885	CcSEcCtD
Reboxetine—Urticaria—Paclitaxel—ovarian cancer	0.000191	0.000885	CcSEcCtD
Reboxetine—Hypotension—Docetaxel—ovarian cancer	0.00019	0.000882	CcSEcCtD
Reboxetine—Connective tissue disorder—Epirubicin—ovarian cancer	0.00019	0.000881	CcSEcCtD
Reboxetine—Abdominal pain—Paclitaxel—ovarian cancer	0.00019	0.00088	CcSEcCtD
Reboxetine—Body temperature increased—Paclitaxel—ovarian cancer	0.00019	0.00088	CcSEcCtD
Reboxetine—Urethral disorder—Epirubicin—ovarian cancer	0.00019	0.000878	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—ovarian cancer	0.000188	0.000871	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—ovarian cancer	0.000187	0.000867	CcSEcCtD
Reboxetine—Visual impairment—Epirubicin—ovarian cancer	0.000186	0.000864	CcSEcCtD
Reboxetine—Insomnia—Docetaxel—ovarian cancer	0.000184	0.000854	CcSEcCtD
Reboxetine—Paraesthesia—Docetaxel—ovarian cancer	0.000183	0.000848	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—ovarian cancer	0.000182	0.000844	CcSEcCtD
Reboxetine—Dyspnoea—Docetaxel—ovarian cancer	0.000182	0.000842	CcSEcCtD
Reboxetine—Somnolence—Docetaxel—ovarian cancer	0.000181	0.000839	CcSEcCtD
Reboxetine—Eye disorder—Epirubicin—ovarian cancer	0.000181	0.000838	CcSEcCtD
Reboxetine—Tinnitus—Epirubicin—ovarian cancer	0.00018	0.000836	CcSEcCtD
Reboxetine—Cardiac disorder—Epirubicin—ovarian cancer	0.00018	0.000832	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—ovarian cancer	0.000179	0.000831	CcSEcCtD
Reboxetine—Dyspepsia—Docetaxel—ovarian cancer	0.000179	0.000831	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—ovarian cancer	0.000178	0.000823	CcSEcCtD
Reboxetine—Decreased appetite—Docetaxel—ovarian cancer	0.000177	0.000821	CcSEcCtD
Reboxetine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000177	0.000821	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000177	0.000819	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000176	0.000815	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000176	0.000815	CcSEcCtD
Reboxetine—Angiopathy—Epirubicin—ovarian cancer	0.000175	0.000813	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—ovarian cancer	0.000175	0.000813	CcSEcCtD
Reboxetine—Immune system disorder—Epirubicin—ovarian cancer	0.000175	0.000809	CcSEcCtD
Reboxetine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000174	0.000808	CcSEcCtD
Reboxetine—Constipation—Docetaxel—ovarian cancer	0.000174	0.000807	CcSEcCtD
Reboxetine—Chills—Epirubicin—ovarian cancer	0.000174	0.000804	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—ovarian cancer	0.000172	0.000799	CcSEcCtD
Reboxetine—Asthenia—Paclitaxel—ovarian cancer	0.000172	0.000799	CcSEcCtD
Reboxetine—Mental disorder—Epirubicin—ovarian cancer	0.000169	0.000785	CcSEcCtD
Reboxetine—Malnutrition—Epirubicin—ovarian cancer	0.000168	0.00078	CcSEcCtD
Reboxetine—Feeling abnormal—Docetaxel—ovarian cancer	0.000168	0.000778	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—ovarian cancer	0.000167	0.000775	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—ovarian cancer	0.000167	0.000773	CcSEcCtD
Reboxetine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000167	0.000772	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000166	0.00077	CcSEcCtD
Reboxetine—Tension—Epirubicin—ovarian cancer	0.000165	0.000766	CcSEcCtD
Reboxetine—Dysgeusia—Epirubicin—ovarian cancer	0.000165	0.000764	CcSEcCtD
Reboxetine—Diarrhoea—Paclitaxel—ovarian cancer	0.000164	0.000762	CcSEcCtD
Reboxetine—Nervousness—Epirubicin—ovarian cancer	0.000164	0.000758	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—ovarian cancer	0.000162	0.000752	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—ovarian cancer	0.000162	0.000749	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000161	0.000747	CcSEcCtD
Reboxetine—Body temperature increased—Docetaxel—ovarian cancer	0.000161	0.000746	CcSEcCtD
Reboxetine—Abdominal pain—Docetaxel—ovarian cancer	0.000161	0.000746	CcSEcCtD
Reboxetine—Chills—Doxorubicin—ovarian cancer	0.000161	0.000744	CcSEcCtD
Reboxetine—Dizziness—Paclitaxel—ovarian cancer	0.000159	0.000736	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—ovarian cancer	0.000157	0.000726	CcSEcCtD
Reboxetine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000156	0.000724	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—ovarian cancer	0.000156	0.000722	CcSEcCtD
Reboxetine—Anaemia—Epirubicin—ovarian cancer	0.000156	0.000721	CcSEcCtD
Reboxetine—Agitation—Epirubicin—ovarian cancer	0.000155	0.000717	CcSEcCtD
Reboxetine—Tension—Doxorubicin—ovarian cancer	0.000153	0.000708	CcSEcCtD
Reboxetine—Vomiting—Paclitaxel—ovarian cancer	0.000153	0.000708	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—ovarian cancer	0.000153	0.000707	CcSEcCtD
Reboxetine—Malaise—Epirubicin—ovarian cancer	0.000152	0.000704	CcSEcCtD
Reboxetine—Rash—Paclitaxel—ovarian cancer	0.000152	0.000702	CcSEcCtD
Reboxetine—Dermatitis—Paclitaxel—ovarian cancer	0.000151	0.000702	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—ovarian cancer	0.000151	0.000701	CcSEcCtD
Reboxetine—Vertigo—Epirubicin—ovarian cancer	0.000151	0.000701	CcSEcCtD
Reboxetine—Syncope—Epirubicin—ovarian cancer	0.000151	0.0007	CcSEcCtD
Reboxetine—Leukopenia—Epirubicin—ovarian cancer	0.000151	0.000698	CcSEcCtD
Reboxetine—Headache—Paclitaxel—ovarian cancer	0.000151	0.000698	CcSEcCtD
Reboxetine—Hypersensitivity—Docetaxel—ovarian cancer	0.00015	0.000695	CcSEcCtD
Reboxetine—Palpitations—Epirubicin—ovarian cancer	0.000149	0.000689	CcSEcCtD
Reboxetine—Loss of consciousness—Epirubicin—ovarian cancer	0.000148	0.000686	CcSEcCtD
Reboxetine—Asthenia—Docetaxel—ovarian cancer	0.000146	0.000677	CcSEcCtD
Reboxetine—Hypertension—Epirubicin—ovarian cancer	0.000145	0.000674	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000145	0.00067	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—ovarian cancer	0.000144	0.000667	CcSEcCtD
Reboxetine—Chest pain—Epirubicin—ovarian cancer	0.000143	0.000664	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—ovarian cancer	0.000143	0.000663	CcSEcCtD
Reboxetine—Anxiety—Epirubicin—ovarian cancer	0.000143	0.000662	CcSEcCtD
Reboxetine—Nausea—Paclitaxel—ovarian cancer	0.000143	0.000662	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000142	0.00066	CcSEcCtD
Reboxetine—Discomfort—Epirubicin—ovarian cancer	0.000142	0.000656	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—ovarian cancer	0.00014	0.000651	CcSEcCtD
Reboxetine—Dry mouth—Epirubicin—ovarian cancer	0.00014	0.00065	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—ovarian cancer	0.00014	0.000649	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—ovarian cancer	0.00014	0.000647	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—ovarian cancer	0.000139	0.000646	CcSEcCtD
Reboxetine—Diarrhoea—Docetaxel—ovarian cancer	0.000139	0.000646	CcSEcCtD
Reboxetine—Confusional state—Epirubicin—ovarian cancer	0.000139	0.000642	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—ovarian cancer	0.000138	0.000638	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000137	0.000634	CcSEcCtD
Reboxetine—Infection—Epirubicin—ovarian cancer	0.000137	0.000633	CcSEcCtD
Reboxetine—Shock—Epirubicin—ovarian cancer	0.000135	0.000626	CcSEcCtD
Reboxetine—Nervous system disorder—Epirubicin—ovarian cancer	0.000135	0.000624	CcSEcCtD
Reboxetine—Dizziness—Docetaxel—ovarian cancer	0.000135	0.000624	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—ovarian cancer	0.000135	0.000623	CcSEcCtD
Reboxetine—Tachycardia—Epirubicin—ovarian cancer	0.000134	0.000621	CcSEcCtD
Reboxetine—Skin disorder—Epirubicin—ovarian cancer	0.000133	0.000618	CcSEcCtD
Reboxetine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000133	0.000616	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—ovarian cancer	0.000133	0.000615	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—ovarian cancer	0.000132	0.000612	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000132	0.00061	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—ovarian cancer	0.000131	0.000607	CcSEcCtD
Reboxetine—Anorexia—Epirubicin—ovarian cancer	0.000131	0.000607	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—ovarian cancer	0.00013	0.000601	CcSEcCtD
Reboxetine—Vomiting—Docetaxel—ovarian cancer	0.00013	0.0006	CcSEcCtD
Reboxetine—Rash—Docetaxel—ovarian cancer	0.000128	0.000595	CcSEcCtD
Reboxetine—Hypotension—Epirubicin—ovarian cancer	0.000128	0.000595	CcSEcCtD
Reboxetine—Dermatitis—Docetaxel—ovarian cancer	0.000128	0.000595	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—ovarian cancer	0.000128	0.000594	CcSEcCtD
Reboxetine—Headache—Docetaxel—ovarian cancer	0.000128	0.000591	CcSEcCtD
Reboxetine—Infection—Doxorubicin—ovarian cancer	0.000126	0.000585	CcSEcCtD
Reboxetine—Shock—Doxorubicin—ovarian cancer	0.000125	0.00058	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000125	0.000578	CcSEcCtD
Reboxetine—Insomnia—Epirubicin—ovarian cancer	0.000124	0.000576	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—ovarian cancer	0.000124	0.000575	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—ovarian cancer	0.000123	0.000572	CcSEcCtD
Reboxetine—Paraesthesia—Epirubicin—ovarian cancer	0.000123	0.000572	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000123	0.00057	CcSEcCtD
Reboxetine—Dyspnoea—Epirubicin—ovarian cancer	0.000123	0.000568	CcSEcCtD
Reboxetine—Somnolence—Epirubicin—ovarian cancer	0.000122	0.000566	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—ovarian cancer	0.000121	0.000562	CcSEcCtD
Reboxetine—Nausea—Docetaxel—ovarian cancer	0.000121	0.000561	CcSEcCtD
Reboxetine—Dyspepsia—Epirubicin—ovarian cancer	0.000121	0.00056	CcSEcCtD
Reboxetine—Decreased appetite—Epirubicin—ovarian cancer	0.000119	0.000553	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—ovarian cancer	0.000119	0.00055	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000119	0.00055	CcSEcCtD
Reboxetine—Constipation—Epirubicin—ovarian cancer	0.000118	0.000544	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—ovarian cancer	0.000115	0.000533	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—ovarian cancer	0.000114	0.000529	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—ovarian cancer	0.000113	0.000525	CcSEcCtD
Reboxetine—Feeling abnormal—Epirubicin—ovarian cancer	0.000113	0.000525	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—ovarian cancer	0.000113	0.000524	CcSEcCtD
Reboxetine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000112	0.000521	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—ovarian cancer	0.000112	0.000519	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—ovarian cancer	0.000111	0.000512	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00011	0.000509	CcSEcCtD
Reboxetine—Urticaria—Epirubicin—ovarian cancer	0.000109	0.000506	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—ovarian cancer	0.000109	0.000504	CcSEcCtD
Reboxetine—Body temperature increased—Epirubicin—ovarian cancer	0.000109	0.000503	CcSEcCtD
Reboxetine—Abdominal pain—Epirubicin—ovarian cancer	0.000109	0.000503	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000105	0.000485	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000104	0.000482	CcSEcCtD
Reboxetine—Hypersensitivity—Epirubicin—ovarian cancer	0.000101	0.000469	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—ovarian cancer	0.000101	0.000468	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—ovarian cancer	0.000101	0.000466	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—ovarian cancer	0.000101	0.000466	CcSEcCtD
Reboxetine—Asthenia—Epirubicin—ovarian cancer	9.86e-05	0.000457	CcSEcCtD
Reboxetine—Diarrhoea—Epirubicin—ovarian cancer	9.4e-05	0.000436	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—ovarian cancer	9.37e-05	0.000434	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—ovarian cancer	9.12e-05	0.000423	CcSEcCtD
Reboxetine—Dizziness—Epirubicin—ovarian cancer	9.09e-05	0.000421	CcSEcCtD
Reboxetine—Vomiting—Epirubicin—ovarian cancer	8.74e-05	0.000405	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—ovarian cancer	8.7e-05	0.000403	CcSEcCtD
Reboxetine—Rash—Epirubicin—ovarian cancer	8.66e-05	0.000401	CcSEcCtD
Reboxetine—Dermatitis—Epirubicin—ovarian cancer	8.66e-05	0.000401	CcSEcCtD
Reboxetine—Headache—Epirubicin—ovarian cancer	8.61e-05	0.000399	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—ovarian cancer	8.41e-05	0.00039	CcSEcCtD
Reboxetine—Nausea—Epirubicin—ovarian cancer	8.16e-05	0.000378	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—ovarian cancer	8.08e-05	0.000375	CcSEcCtD
Reboxetine—Rash—Doxorubicin—ovarian cancer	8.02e-05	0.000371	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—ovarian cancer	8.01e-05	0.000371	CcSEcCtD
Reboxetine—Headache—Doxorubicin—ovarian cancer	7.97e-05	0.000369	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—ovarian cancer	7.55e-05	0.00035	CcSEcCtD
